OncoCyte Corp (OCX) — Capital Reinvestment Ratio
Latest as of September 2014:
1.86x
OncoCyte Corp (OCX) has a Capital Reinvestment Ratio of 1.86x as of September 2014, meaning it reinvests 2% of its operating cash flow ($7.00K) in capital expenditures ($13.00K). See OncoCyte Corp (OCX) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
1.86x
Capex / Operating Cash Flow
Operating Cash Flow
$7.00K
USD
Capital Expenditures
$13.00K
USD
Data as of
Sep 2014
Most recent filing
Annual Capital Reinvestment Ratio for OncoCyte Corp (None–None)
Year-by-year Capital Reinvestment Ratio for OncoCyte Corp from None to None. For live market cap and broader valuation context, see market cap of OncoCyte Corp.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow